Literature DB >> 20009783

The suprameatal approach: a safe alternative surgical technique for cochlear implantation.

Job T F Postelmans1, Rinze A Tange, Robert J Stokroos, Wilko Grolman.   

Abstract

OBJECTIVE: To report on surgical complications arising postoperatively in 104 patients undergoing cochlear implantation surgery using the suprameatal approach (SMA). Second, to examine the advantages and disadvantages of the SMA technique compared with the classic mastoidectomy using the posterior tympanotomy approach. STUDY
DESIGN: Retrospective study assessing surgical complications in deaf adults and children undergoing cochlear implantation.
SETTING: Tertiary referral center for cochlear implantation (Academic Medical Centre). PATIENTS: The mean age at the time of surgery was 39.6 years (1.0-82.3 yr), and the mean duration of deafness was 26.3 years (0.3-66.0 yr). The main cause was a congenital hearing loss (30.8%) and a progressive sensorineural hearing loss e.c.i. (25.0%), followed by meningitis (12.5%) and otosclerosis (6.7%). The mean duration of follow-up after surgery was 25.7 months (range, 3.0-59.0 mo).
RESULTS: The overall major complication rate was 3.7% (4 of 107). All complications developed postoperatively. The major complications consisted of extrusion of the implant due to wound infection (n = 2), a wrong route for the electrode (n = 1), and device failure (n = 1). The minor complication rate was 23.4% (25 of 107). The mean time taken for cochlear implantation was 111.7 minutes (range, 60.0-261.1 min).
CONCLUSION: This study confirms the SMA is a safe, simple, and quick technique that is feasible for cochlear implantation in most cases. Although the stretching of the electrode array when it enters the scala tympani and a low-lying dura could present a potential restriction for the SMA technique, our results do not support this hypothesis.

Entities:  

Mesh:

Year:  2010        PMID: 20009783     DOI: 10.1097/MAO.0b013e3181c29f8b

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  7 in total

1.  Long-term results of the transattical approach: an alternative technique for cochlear implantation.

Authors:  Miguel Vaca; Auxiliadora Gutiérrez; Rubén Polo; Antonio Alonso; Felipe Álvarez
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-11-29       Impact factor: 2.503

2.  Residual hearing preservation using the suprameatal approach for cochlear implantation.

Authors:  Christoph Arnoldner; Wolfgang Gstoettner; Dominik Riss; Jens Wagenblast; Clemens Honeder; Michaela Blineder; Jafar-Sasan Hamzavi; Alexandra Jappel; Wolf-Dieter Baumgartner
Journal:  Wien Klin Wochenschr       Date:  2011-08-25       Impact factor: 1.704

3.  Cochlear implantation in children with CHARGE syndrome: a report of eight cases.

Authors:  Vincenzo Vincenti; Filippo Di Lella; Maurizio Falcioni; Maurizio Negri; Diego Zanetti
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-07-03       Impact factor: 2.503

4.  Cochlear implantation in children with "CHARGE syndrome": surgical options and outcomes.

Authors:  Giampietro Ricci; Franco Trabalzini; Mario Faralli; Luca D'Ascanio; Cristina Cristi; Egisto Molini
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-03-24       Impact factor: 2.503

5.  Virtual exploration and comparison of linear mastoid drilling trajectories with true-color volume rendering and the visible ear dataset.

Authors:  Lueder A Kahrs; Robert F Labadie
Journal:  Stud Health Technol Inform       Date:  2013

6.  Comparison of two cochlear implantation techniques and their effects on the preservation of residual hearing. Is the surgical approach of any importance?

Authors:  J T F Postelmans; R J Stokroos; E van Spronsen; W Grolman; R A Tange; M J Maré; Wouter Albert Dreschler
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-04-30       Impact factor: 2.503

7.  Cochlear implantation using a suprameatal approach in a case of severely contracted mastoid cavity.

Authors:  Ji Eun Choi; Jeon Yeob Jang; Yang-Sun Cho
Journal:  Korean J Audiol       Date:  2014-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.